Skip to content

Clinical trials

Diabetes Mellitus, Type 1 trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Country / region: China Clear all

92 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20052
20062
20071
20083
20091
20106
20111
20122
20135
20142
20154
20164
20174
20183
20196
20206
20212
20228
20233
20249
202511
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Unknown status27
Recruiting24
Not yet recruiting5
Active, not recruiting2
Terminated1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Second Xiangya Hospital of Central South University17
Novo Nordisk A/S6
Eli Lilly and Company5
Shanghai Jiao Tong University School of Medicine4
Fuzhou General Hospital3
Medtronic MiniMed, Inc.3
Nanjing Medical University3
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School3
Third Affiliated Hospital, Sun Yat-Sen University3
Throne Biotechnologies Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 192
Diabetes Mellitus19
Diabetes Mellitus, Type 218
Autoimmune Diseases5
Insulin Resistance3
Endocrine System Diseases2
Erectile Dysfunction2
Glucose Metabolism Disorders2
Hypoglycemia2
Immune System Diseases2

Trials

Showing 76 to 92 of 92. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.